Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.